Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Monika, Semmrich"'
Autor:
Monika Semmrich, Linda Mårtensson, Ingrid Teige, Björn Frendeus, Mathilda Kovacek, Petra Holmkvist, Carolin Svensson, Therese Blidberg, Andres McAllister, Marie Borggren, Ingrid Karlsson, Mark Cragg, Mimoza Bodén, Kirstie Cleary, Osman Dadas, Benjamin Duell, Jan Anders Nilsson, Stephen Beers, Sean Lim, Johan E Wallin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e0e8b870548644bdb65e3e93dec0f252
Autor:
Laetitia Fend, Eric Quemeneur, Monika Semmrich, Jean-Baptiste Marchand, Matilda Rehn, Nathalie Silvestre, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendeus, Petra Holmkvist, Carolin Svensson, Christelle Remy, Patricia Kleinpeter, Jules Deforges, Fred Junghus, Kirstie L Cleary, Mimoza Bodén
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/715bfd92355a4c01a650b6be33e6abb9
Autor:
Laetitia Fend, Eric Quemeneur, Monika Semmrich, Jean-Baptiste Marchand, Matilda Rehn, Nathalie Silvestre, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendeus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/60f9adc19c7a452191469affca81e1df
Autor:
Monika Semmrich, Linda Mårtensson, Ingrid Teige, Björn Frendeus, Mathilda Kovacek, Petra Holmkvist, Carolin Svensson, Therese Blidberg, Carl Roos, Andres McAllister, Mimoza Demiri, Marie Borggren, Ingrid Karlsson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/baba49f749e844cd8cfdc68f13573c43
Autor:
C Ian Mockridge, Kerry L Cox, Martin J Glennie, Mark S Cragg, Monika Semmrich, Linda Mårtensson, Ingrid Teige, Jordana Griffiths, Khiyam Hussain, Hannah L Smith, Theodore Sanders, Jinny Kim, Tatyana Inzhelevskaya, Chris A Penfold, Alison L Tutt, HT Claude Chan, Vikki English, Ruth F French, Bjorn L Frendeus, Jane E Willoughby
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Previous data suggests that anti-OX40 mAb can elicit anti-tumor effects in mice through deletion of Tregs. However, OX40 also has powerful costimulatory effects on T cells which could evoke therapeutic responses. Human trials with anti-OX4
Externí odkaz:
https://doaj.org/article/86d9cb4f413b4935a92592aca78649b9
Autor:
Monika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, Matilda Rehn, Christelle Remy, Petra Holmkvist, Nathalie Silvestre, Carolin Svensson, Patricia Kleinpeter, Jules Deforges, Fred Junghus, Kirstie L Cleary, Mimoza Bodén, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Eric Quéméneur, Björn Frendéus
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
BackgroundImmune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of patients with cancer including those with poorly immune infiltrated ‘cold’ tumors are resistant to currently available ICB therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422945ff6754e9a6ad3d2b4f27d8959c
https://jitc.bmj.com/content/10/1/e003488.full
https://jitc.bmj.com/content/10/1/e003488.full
Autor:
Monika, Semmrich, Jean-Baptiste, Marchand, Laetitia, Fend, Matilda, Rehn, Christelle, Remy, Petra, Holmkvist, Nathalie, Silvestre, Carolin, Svensson, Patricia, Kleinpeter, Jules, Deforges, Fred, Junghus, Kirstie L, Cleary, Mimoza, Bodén, Linda, Mårtensson, Johann, Foloppe, Ingrid, Teige, Eric, Quéméneur, Björn, Frendéus
Publikováno v:
Journal for Immunotherapy of Cancer
Background Immune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of patients with cancer including those with poorly immune infiltrated ‘cold’ tumors are resistant to currently available ICB therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09bd94ed6325ee24b261cd0627e28c52
https://pubmed.ncbi.nlm.nih.gov/35058324
https://pubmed.ncbi.nlm.nih.gov/35058324
Autor:
Linda Mårtensson, Kirsty Cleary, Petra Holmkvist, Mathilda Kovacek, Carolin Svensson, Monika Semmrich, Therese Blidberg, Mimoza Demiri, Osman Dadas, Marie Borggren, Vici Pitic, Sean H. Lim, Stephen A. Beers, Susanne Gertsson, Kristoffer S. Rohrberg, Ingrid Karlsson, Andres McAllister, Mark S. Cragg, Björn Frendeus, Ingrid Teige
Publikováno v:
Cancer Research. 82:4156-4156
The pleiotropic TNF-α:TNFR axis plays a central role in immune regulation. While the cellular expression of TNFR1 is broad, TNFR2 expression is mainly restricted to immune cells. The therapeutic potential of targeting TNFR2 for cancer treatment has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a48fd1dbbe02c1299113b91d04509751
https://doi.org/10.1158/1538-7445.am2022-4156
https://doi.org/10.1158/1538-7445.am2022-4156
Autor:
Jean-Baptiste Marchand, Monika Semmrich, Christelle Ziller, Matilda Rehn, Laetitia Fend, Petra Holmkvist, Nathalie Silvestre, Carolin Svensson, Kleinpeter Patricia, Jules Deforges, Fred Junghus, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Björn Frendéus, Eric Quéméneur
Publikováno v:
Cancer Research. 82:3567-3567
Background Immune checkpoint blockade (ICB) is a clinically proven concept to treat cancer. Still, a majority of cancer patients including those with poorly immune infiltrated “cold” tumors are resistant to currently available ICB therapies. Onco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b43b28ad955ed7dc3b41cd5a960182
https://doi.org/10.1158/1538-7445.am2022-3567
https://doi.org/10.1158/1538-7445.am2022-3567
Autor:
Claude H.T. Chan, Hannah L Smith, Theodore Sanders, Mark S. Cragg, Vikki English, Björn Frendéus, Martin J. Glennie, Ingrid Teige, Jordana Griffiths, Ruth R. French, Khiyam Hussain, Chris Penfold, Kerry L. Cox, Jane E. Willoughby, Tatyana Inzhelevskaya, Alison L. Tutt, Ian M Mockridge, Monika Semmrich, Jinny Kim, Aymen Al-Shamkhani, Linda Mårtensson
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundPrevious data suggests that anti-OX40 mAb can elicit anti-tumor effects in mice through deletion of Tregs. However, OX40 also has powerful costimulatory effects on T cells which could evoke therapeutic responses. Human trials with anti-OX40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5298aead16bc1b468e07964d3f14d5f
https://pubmed.ncbi.nlm.nih.gov/33428585
https://pubmed.ncbi.nlm.nih.gov/33428585